Ono Pharmaceutical (OTCMKTS:OPHLF) Shares Gap Up – Here’s What Happened

Ono Pharmaceutical Co. (OTCMKTS:OPHLF) shares gapped up before the market opened on Wednesday. The stock had previously closed at $15.00, but opened at $16.11. Ono Pharmaceutical shares last traded at $16.11, with a volume of 300 shares.

Wall Street Analyst Weigh In

Separately, Zacks Research cut Ono Pharmaceutical from a “strong-buy” rating to a “hold” rating in a research report on Friday, September 4th. One research analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold”.

Ono Pharmaceutical Price Performance

The company has a quick ratio of 2.86, a current ratio of 3.28 and a debt-to-equity ratio of 0.08. The stock has a market capitalization of $7.57 billion, a PE ratio of 15.34 and a beta of 0.33. The firm’s fifty day moving average is $14.93 and its 200-day moving average is $14.61.

Ono Pharmaceutical Company Profile

Ono Pharmaceutical Co, Ltd. is a Japanese research-driven pharmaceutical company headquartered in Osaka. The company discovers, develops, manufactures and markets prescription medicines, with a focus on oncology, immunology, neurology and other specialty-care areas. Its activities include both internally developed products and collaborations with pharmaceutical and biotechnology companies worldwide.

Ono is best known internationally for Opdivo (nivolumab), an immune checkpoint inhibitor developed in collaboration with Bristol Myers Squibb and used to treat multiple types of cancer.